Pura Vida Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-75,000
Closed -$1.2M 115
2022
Q4
$1.2M Hold
75,000
0.06% 143
2022
Q3
$1.18M Hold
75,000
0.07% 153
2022
Q2
$1.56M Buy
+75,000
New +$1.55M 0.09% 149
2021
Q3
Sell
-51,779
Closed -$943K 295
2021
Q2
$943K Sell
51,779
-14,681
-22% -$342K 0.03% 184
2021
Q1
$1.5M Buy
+66,460
New +$1.5M 0.04% 175
2019
Q1
Sell
-86,055
Closed -$1.69M 112
2018
Q4
$1.69M Buy
+86,055
New +$1.53M 0.34% 46
2018
Q2
Sell
-40,000
Closed -$886K 103
2018
Q1
$886K Sell
40,000
-40,000
-50% -$1.11M 0.52% 47
2017
Q4
$2.43M Buy
+80,000
New +$2.13M 1.02% 40

Other funds holding EXEL

Pura Vida Investments's EXEL Position: Q1 2023 in Review

Pura Vida Investments sold out of Exelixis (EXEL) in Q1 2023, closing a stake of 75,000 shares — an estimated $1.2M sold.

Pura Vida Investments first reported a position in EXEL in Q4 2017 and held it in 8 quarters. The position peaked at $2.43M in Q4 2017. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2023.

  • Pura Vida Investments reported no remaining Exelixis position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 75,000 Exelixis shares in Q1 2023, an estimated $1.2M.
  • Pura Vida Investments first reported a position in Exelixis in Q4 2017 and held it in 8 quarters.
  • Pura Vida Investments's Exelixis position peaked at $2.43M in Q4 2017.
  • 363 funds tracked by Wall St. Rank held Exelixis as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.